Cargando…

Formulation, Characterization, and Evaluation of Eudragit-Coated Saxagliptin Nanoparticles Using 3 Factorial Design Modules

Background and Introduction: Saxagliptin is a hypoglycemic drug that acts as a dipeptidyl peptidase-4 (DPP-4) inhibitor and is preferably used in the treatment of Type 2 Diabetes Mellitus (T2DM). It is safe and tolerable; however, the major disadvantage associated with it is its low bioavailability....

Descripción completa

Detalles Bibliográficos
Autores principales:	Alhamhoom, Yahya, Ravi, Gundawar, Osmani, Riyaz Ali M., Hani, Umme, Prakash, Gowrav M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653823/ https://www.ncbi.nlm.nih.gov/pubmed/36364338 http://dx.doi.org/10.3390/molecules27217510

Ejemplares similares

Study of Formulation and Process Variables for Optimization of Piroxicam Nanosuspension Using 3(2) Factorial Design to Improve Solubility and In Vitro Bioavailability
por: Alhamhoom, Yahya, et al.
Publicado: (2023)

Development and Evaluation of Solid Lipid Nanoparticles for the Clearance of Aβ in Alzheimer’s Disease
por: Shivananjegowda, Meghana Goravinahalli, et al.
Publicado: (2023)

Revolutionizing Drug Delivery and Therapeutics: The Biomedical Applications of Conductive Polymers and Composites-Based Systems
por: Paramshetti, Sharanya, et al.
Publicado: (2023)

Recent advances in the liposomal nanovesicles based immunotherapy in the treatment of cancer: A review
por: Alhamhoom, Yahya, et al.
Publicado: (2023)

Preparation and Evaluation of Mixture of Eudragit and Ethylcellulose Microparticles Loaded with Ranolazine for Controlled Release
por: Gowda, DV, et al.
Publicado: (2011)

Eudragit nanoparticles containing genistein: formulation, development, and bioavailability assessment
por: Tang, Jingling, et al.
Publicado: (2011)

Data on statistical experimental design to formulate amphotericin B-loaded Eudragit RL100 nanoparticles coated with hyaluronic acid for the treatment of vulvovaginal candidiasis
por: Melo, Carolina M., et al.
Publicado: (2020)

Sustainable Stabilizer-Free Nanoparticle Formulations of Valsartan Using Eudragit(®) RLPO
por: Hajba-Horváth, Eszter, et al.
Publicado: (2021)

Development and Characterization of Oral Raft Forming In Situ Gelling System of Neratinib Anticancer Drug Using 3(2) Factorial Design
por: Hani, Umme, et al.
Publicado: (2022)

Development of stealth liposomal formulation of celecoxib: In vitro and in vivo evaluation
por: Begum, M. Yasmin, et al.
Publicado: (2022)

Eudragit S100 Coated Citrus Pectin Nanoparticles for Colon Targeting of 5-Fluorouracil
por: Subudhi, M. Biswaranjan, et al.
Publicado: (2015)

Design, Preparation, and Evaluation of Enteric Coating Formulation of HPMC and Eudragit L100 on Carboxylated Agarose Hydrogel by Using Drug Tartrazine
por: Khan, Muhammad Junaid, et al.
Publicado: (2022)

Formulation and optimisation of lamivudine‐loaded Eudragit(®) S 100 polymer‐coated pectin microspheres for colon‐specific delivery
por: Vilas, Satheesh, et al.
Publicado: (2021)

Smart Nanocarriers as an Emerging Platform for Cancer Therapy: A Review
por: Kenchegowda, Madhuchandra, et al.
Publicado: (2021)

Preparation and characterization of Eudragit L 100-55/chitosan enteric nanoparticles containing omeprazole using general factorial design: in vitro/in vivo study
por: Rezazadeh, Mahboubeh, et al.
Publicado: (2021)

Formulation and in vitro evaluation of Eudragit S-100 coated naproxen matrix tablets for colon-targeted drug delivery system
por: Mehta, Rohit, et al.
Publicado: (2013)

Tamoxifen-Loaded Eudragit Nanoparticles: Quality by Design Approach for Optimization of Nanoparticles as Delivery System
por: Khattak, Muzna Ali, et al.
Publicado: (2023)

Preparation and Optimization of Ibrutinib-Loaded Nanoliposomes Using Response Surface Methodology
por: Ashar, Fareeaa, et al.
Publicado: (2022)

Formulation and Evaluation of Eudragit RL-100 Nanoparticles Loaded In-Situ Forming Gel for Intranasal Delivery of Rivastigmine
por: Salatin, Sara, et al.
Publicado: (2020)

Eluxadoline-Loaded Eudragit Nanoparticles for Irritable Bowel Syndrome with Diarrhea: Formulation, Optimization Using Box–Behnken Design, and Anti-Diarrheal Activity
por: Anwer, Md. Khalid, et al.
Publicado: (2023)

Carvedilol Precipitation Inhibition by the Incorporation of Polymeric Precipitation Inhibitors Using a Stable Amorphous Solid Dispersion Approach: Formulation, Characterization, and In Vitro In Vivo Evaluation
por: Ravikumar, Akhila Akkihebbal, et al.
Publicado: (2022)

Optimized Rivastigmine Nanoparticles Coated with Eudragit for Intranasal Application to Brain Delivery: Evaluation and Nasal Ciliotoxicity Studies
por: Bhanderi, Mansi, et al.
Publicado: (2021)

Fabrication, characterization, and evaluation of microsponge delivery system for facilitated fungal therapy
por: Moin, Afrasim, et al.
Publicado: (2016)

Performance of Eudragit Coated Whispering Gallery Mode Resonator-Based Immunosensors
por: Giannetti, Ambra, et al.
Publicado: (2012)

Formulation and in vitro Evaluation of Alfuzosin Extended Release Tablets Using Directly Compressible Eudragit
por: Roni, M. A., et al.
Publicado: (2009)

Formulation and optimization of temozolomide nanoparticles by 3 factor 2 level factorial design
por: Jain, Aviral, et al.
Publicado: (2013)

Anticancer Potential of Temozolomide-Loaded Eudragit-Chitosan Coated Selenium Nanoparticles: In Vitro Evaluation of Cytotoxicity, Apoptosis and Gene Regulation
por: Mazarei, Madineh, et al.
Publicado: (2021)

Hyaluronan–cisplatin conjugate nanoparticles embedded in Eudragit S100-coated pectin/alginate microbeads for colon drug delivery
por: Tsai, Shiao-Wen, et al.
Publicado: (2013)

Eudragit(®)-S100 Coated PLGA Nanoparticles for Colon Targeting of Etoricoxib: Optimization and Pharmacokinetic Assessments in Healthy Human Volunteers
por: El-Maghawry, Enas, et al.
Publicado: (2020)

Preparation, Evaluation and Bioavailability Studies of Eudragit Coated PLGA Nanoparticles for Sustained Release of Eluxadoline for the Treatment of Irritable Bowel Syndrome
por: Anwer, Md. K., et al.
Publicado: (2017)

Development of a Curcumin Bioadhesive Monolithic Tablet for Treatment of Vaginal Candidiasis
por: Hani, Umme, et al.
Publicado: (2016)

Formulation, Optimization, In Vitro and In Vivo Evaluation of Saxagliptin-Loaded Lipospheres for an Improved Pharmacokinetic Behavior
por: Rasul, Akhtar, et al.
Publicado: (2021)

Design of eudragit RL nanoparticles by nanoemulsion method as carriers for ophthalmic drug delivery of ketotifen fumarate
por: Soltani, Saieede, et al.
Publicado: (2016)

Amperometric Monitoring of Dissolution of pH-Responsive EUDRAGIT(®) Polymer Film Coatings
por: Mestres, Júlia, et al.
Publicado: (2022)

The effect of pectin on swelling and permeability characteristics of free films containing Eudragit RL and/or RS as a coating formulation aimed for colonic drug delivery
por: Akhgari, A., et al.
Publicado: (2010)

Saxagliptin for type 2 diabetes
por: Chacra, Antonio R
Publicado: (2010)

Newfangled Topical Film-Forming Solution for Facilitated Antifungal Therapy: Design, Development, Characterization, and In Vitro Evaluation
por: Dhimmar, Bhakti, et al.
Publicado: (2023)

Fabrication and optimization of camptothecin loaded Eudragit S 100 nanoparticles by Taguchi L4 orthogonal array design
por: Mahalingam, Manikandan, et al.
Publicado: (2015)

Uptake of Eudragit Retard L (Eudragit(®) RL) Nanoparticles by Human THP-1 Cell Line and Its Effects on Hematology and Erythrocyte Damage in Rats
por: Abdel-Wahhab, Mosaad A., et al.
Publicado: (2014)

Comparison of Simple Eudragit Microparticles Loaded with Prednisolone and Eudragit-Coated Chitosan-Succinyl-Prednisolone Conjugate Microparticles: Part II. In Vivo Evaluation of Efficacy, Toxicity, and Biodisposition Characteristics
por: Onishi, Hiraku, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_9a63o395s78m18qovofsilcvvn